Atropine

Article Details

Citation
Copy to clipboard

McLendon K, Preuss CV

Atropine

.

PubMed ID
29262018 [ View in PubMed
]
Abstract

Atropine or atropine sulfate carries FDA indications for anti-sialagogue/anti-vagal effect, organophosphate/muscarinic poisoning, and bradycardia. Atropine acts as a competitive, reversible antagonist of muscarinic receptors: an anticholinergic drug. This activity outlines the indications, mechanism of action, safe administration, adverse effects, contraindications, toxicology, and monitoring of atropine.

DrugBank Data that Cites this Article

Drugs